Lou Sun

Taitung, TNQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

Long-term systemic outcomes of postmenopausal hormone replacement therapy by age at menopause: a real-world cohort study.

Long-term systemic outcomes of postmenopausal hormone replacement therapy by age at menopause: a real-world cohort study.

Journal: Human reproduction open

Published: March 30, 2026

Association of hormone therapy with long-term outcomes after chemoradiation for locally advanced cervical cancer.

Association of hormone therapy with long-term outcomes after chemoradiation for locally advanced cervical cancer.

Journal: American journal of obstetrics and gynecology

Published: February 06, 2026

Comparative safety of PD-1 and PD-L1 inhibitors in advanced solid tumors: a real-world cohort study with competing risk analysis.

Comparative safety of PD-1 and PD-L1 inhibitors in advanced solid tumors: a real-world cohort study with competing risk analysis.

Journal: Cancer immunology, immunotherapy : CII

Published: October 27, 2025

Long-term risk of psychiatric disorders in women with endometriosis: A retrospective cohort study.

Long-term risk of psychiatric disorders in women with endometriosis: A retrospective cohort study.

Journal: Comprehensive psychiatry

Published: August 15, 2025

Lenvatinib Plus Pembrolizumab versus Doxorubicin for Advanced or Recurrent Endometrial Cancer with Short Treatment-Free Intervals Following First-Line Carboplatin Plus Paclitaxel.

Lenvatinib Plus Pembrolizumab versus Doxorubicin for Advanced or Recurrent Endometrial Cancer with Short Treatment-Free Intervals Following First-Line Carboplatin Plus Paclitaxel.

Journal: Journal of clinical medicine

Published: July 04, 2024

Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer.

Lenvatinib plus pembrolizumab compared to carboplatin plus paclitaxel for carboplatin and paclitaxel pretreated, recurrent, or advanced endometrial cancer.

Journal: BMC medicine

Published: May 08, 2024

A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma.

A retrospective study evaluating the effect of trastuzumab addition to carboplatin/paclitaxel on overall survival in patients with advanced-stage HER2/neu-overexpressing uterine serous carcinoma or carcinosarcoma.

Journal: BMC medicine

Published: May 05, 2024

Maintenance Chemotherapy in Patients with Platinum-Sensitive Relapsed Epithelial Ovarian Cancer after Second-Line Chemotherapy.

Maintenance Chemotherapy in Patients with Platinum-Sensitive Relapsed Epithelial Ovarian Cancer after Second-Line Chemotherapy.

Journal: Journal of clinical medicine

Published: December 03, 2023

Consistency in human papillomavirus type detection between self-collected vaginal specimens and physician-sampled cervical specimens.

Consistency in human papillomavirus type detection between self-collected vaginal specimens and physician-sampled cervical specimens.

Journal: Journal of medical virology

Published: November 27, 2023

Case report: Malignant transformation of ovarian endometrioma during long term use of dienogest in a young lady.

Case report: Malignant transformation of ovarian endometrioma during long term use of dienogest in a young lady.

Journal: Frontiers in oncology

Published: November 14, 2023

Evaluation of a novel vaginal cells self-sampling device for human papillomavirus testing in cervical cancer screening: A clinical trial assessing reliability and acceptability.

Evaluation of a novel vaginal cells self-sampling device for human papillomavirus testing in cervical cancer screening: A clinical trial assessing reliability and acceptability.

Journal: Bioengineering & translational medicine

Published: November 07, 2023

Long-term outcome of minimally invasive staging surgery for clinical stage I endometrial cancer: A single institute experience in Taiwan.

Long-term outcome of minimally invasive staging surgery for clinical stage I endometrial cancer: A single institute experience in Taiwan.

Journal: Journal of the Chinese Medical Association : JCMA

Published: October 04, 2023

Showing 1-12 of 21

Last Updated: 09/26/2026